AXIS Webinar: Market access implications of the new Irish IPHA / HSE framework agreement

Back to Posts

On January 25th, 2022,  AXIS CEO along with Senior HTA Manager, Cillian Copeland provided insights on the nuances to the recently signed Framework Agreement for the Supply and Pricing of Medicines in Ireland. With well over a hundred attendees the event took a “ behind the scenes” look at the process involved in negotiating this new framework agreement (FASPM) with the Health Service Executive (HSE) the Department of Health ( DOH) the Department of Public Expenditure and Reform (DEPR) and the Irish Pharmaceutical Health Association (IPHA). The event featured an excellent presentation by our guest presenter, Jim McGrath, Director for Commercial Policy at IPHA.

The feedback to the event has been hugely positive and the focus we placed on teasing through the market access implications of FASPM has been especially valued by the attendees. Thanks to all who joined the event!


More events to follow so check back on our EVENTS page for updates.

Back to Posts